Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $114.1 million.

  • Burning Rock Biotech's Liabilities and Shareholders Equity fell 1870.39% to $114.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $468.3 million, marking a year-over-year decrease of 1697.3%. This contributed to the annual value of $121.3 million for FY2024, which is 1719.94% down from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Liabilities and Shareholders Equity is $114.1 million, which was down 1870.39% from $115.2 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Liabilities and Shareholders Equity registered a high of $659.4 million during Q4 2021, and its lowest value of $114.1 million during Q3 2025.
  • For the 5-year period, Burning Rock Biotech's Liabilities and Shareholders Equity averaged around $237.1 million, with its median value being $183.5 million (2023).
  • In the last 5 years, Burning Rock Biotech's Liabilities and Shareholders Equity skyrocketed by 6157.73% in 2021 and then tumbled by 6509.76% in 2022.
  • Over the past 5 years, Burning Rock Biotech's Liabilities and Shareholders Equity (Quarter) stood at $659.4 million in 2021, then tumbled by 65.1% to $230.2 million in 2022, then plummeted by 36.36% to $146.5 million in 2023, then fell by 17.2% to $121.3 million in 2024, then dropped by 5.94% to $114.1 million in 2025.
  • Its Liabilities and Shareholders Equity was $114.1 million in Q3 2025, compared to $115.2 million in Q2 2025 and $117.8 million in Q1 2025.